CK-MB IN SERUM AND IN HEART AND SKELETAL-MUSCLES IN PATIENTS SUBJECTED TO MITRAL-VALVE REPLACEMENT

Abstract

Serum catalytic concentrations of total creatine kinase (CK) and its more heartspecific isoenzyme CK-MB were studied in 25 consecutive patients subjected to isolated mitral valve replacement (Bjork-Shiley prosthesis). Heart and skeletal muscle CK and CK-MB content was determined in 10 cases. The postoperative serum levels did not reflect differences in myocardial CK-MB content between patients. CK-MB as a percentage of total CK at peak serum CK-MB (16 .+-. 1%) (mean .+-. SEM) was of similar order as the percentage of CK-MB in the myocardium (papillary muscle 20.9 .+-. 1.3%, right auricle 18.2 .+-. 0.5%). A small proportion of CK-MB was present in all skeletal muscle samples examined (diaphragm 4.2 .+-. 0.6%, rectus abdominis 0.4 .+-. 0.1%), indicating that the total CK level should be taken into account in attempts to determine the origin of a raised postoperative serum CK-MB activity. The degree of postoperative CK-MB elevation was related to the duration of operation and of aortic cross-clamping. Perioperative myocardial infarction occurred in 1 patient. Serum CK-MB kinetics in this patient, with a biphasic enzyme curve, differed from those in the other patients.